Elbasvir
Elbasvir
Elbasvir (pronounced el-BAS-vir) is an antiviral drug used in the treatment of hepatitis C. It is often used in combination with another antiviral drug, grazoprevir, in a medication known as Zepatier.
Etymology
The name "Elbasvir" is derived from a combination of letters from the names of the two companies that developed the drug, Merck and Schering-Plough. The "Elb" comes from "Merck", and the "asvir" is a common suffix for antiviral drugs.
Usage
Elbasvir is used to treat chronic hepatitis C, a viral infection that can lead to serious liver problems including cirrhosis and liver cancer. It is used in combination with grazoprevir, another antiviral drug, in a medication known as Zepatier. This combination is used to treat hepatitis C genotypes 1 and 4.
Mechanism of Action
Elbasvir works by inhibiting the HCV NS5A protein, which is essential for viral replication. By blocking this protein, elbasvir prevents the virus from multiplying, which reduces the amount of hepatitis C virus in the body.
Side Effects
Common side effects of elbasvir include fatigue, headache, and nausea. More serious side effects can include liver problems and reactivation of hepatitis B in people who have previously had the disease.
Related Terms
External links
- Medical encyclopedia article on Elbasvir
- Wikipedia's article - Elbasvir
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski